Tevogen Bio Holdings (TVGN) Operating Leases (2023 - 2026)

Tevogen Bio Holdings has reported Operating Leases for 4 years, with the latest figure at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $1.1 million, up 19271.12% from the prior year.
• Operating Leases for Q1 2026 stood at $1.1 million, down from $1.1 million in the prior quarter.
• The five-year high for Operating Leases was $1.2 million in Q2 2025, with the low at $5796.0 in Q4 2024.
• Historically, Operating Leases has averaged $565688.4 across 4 years, with a median of $234858.0 in 2023.
• Annual changes were most pronounced in 2024 — Operating Leases plunged 97.53% — and 2025, when it jumped 19271.12%.
• Tevogen Bio Holdings' Operating Leases stood at $234858.0 in 2023, then sank by 97.53% to $5796.0 in 2024, then jumped by 19271.12% to $1.1 million in 2025, then dropped by 2.56% to $1.1 million in 2026.
• The last three Operating Leases figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.